We are live on ! Find out more
ANTH

Anthera Pharmaceuticals, Inc.
ANTH

Delisted

ANTH was delisted on the 27th of June, 2018.

Back to rankings

35 hedge funds and large institutions have $32.9M invested in Anthera Pharmaceuticals, Inc. in 2013 Q2 according to their latest regulatory filings, with 35 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
35
Holders Change
+35
Holders Change %
–
% of All Funds
1.14%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.07%
New
35
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
SM
1
Sabby Management
Florida
$7.07M +$8.9M +238,423 New
DM
2
Deerfield Management
New York
$6.43M +$8.1M +217,085 New
O
3
OrbiMed
New York
$3.43M +$4.35M +116,594 New
BI
4
BVF Inc
California
$2.07M +$2.61M +69,953 New
BC
5
Broadfin Capital
New York
$1.95M +$2.45M +65,625 New
A
6
Abingworth
United Kingdom
$1.73M +$2.04M +54,749 New
Franklin Resources
7
Franklin Resources
California
$1.61M +$2.03M +54,427 New
PA
8
Perceptive Advisors
New York
$1.6M +$2.01M +53,932 New
Vanguard Group
9
Vanguard Group
Pennsylvania
$1.29M +$1.63M +43,603 New
MCM
10
Moore Capital Management
New York
$926K +$1.17M +31,250 New
B
11
Bailard
California
$896K +$1.13M +30,232 New
Deutsche Bank
12
Deutsche Bank
Germany
$681K +$859K +23,026 New
VM
13
VHCP Management
New York
$666K +$838K +22,463 New
JG
14
Jefferies Group
New York
$505K +$640K +17,155 New
JGC
15
J. Goldman & Co
New York
$463K +$583K +15,625 New
UOC
16
UBS O'Connor
Illinois
$278K +$350K +9,375 New
Alyeska Investment Group
17
Alyeska Investment Group
Illinois
$270K +$340K +9,100 New
BIT
18
BlackRock Institutional Trust
California
$222K +$280K +7,496 New
Geode Capital Management
19
Geode Capital Management
Massachusetts
$208K +$261K +7,005 New
Renaissance Technologies
20
Renaissance Technologies
New York
$141K +$177K +4,743 New
Citigroup
21
Citigroup
New York
$135K +$170K +4,563 New
U
22
UBS
Switzerland
$111K +$140K +3,746 New
Northern Trust
23
Northern Trust
Illinois
$49K +$61.3K +1,642 New
EEG
24
E.E. Geduld
$46K +$58.3K +1,563 New
Jane Street
25
Jane Street
New York
$44K +$55.7K +1,493 New
1
2

ANTH Hedge Fund Activity: Q2 2013 in Review

35 of the 3,065 institutional investors tracked by Wall St. Rank reported a position in Anthera Pharmaceuticals, Inc. (ANTH) for Q2 2013, worth a combined $32.9M.

Buyers outnumbered sellers: 35 funds opened new ANTH positions and 0 closed out — a net gain of 35 holders — while 0 added to existing stakes and 0 trimmed.

  • 35 institutional investors held Anthera Pharmaceuticals, Inc. (ANTH) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $32.9M of Anthera Pharmaceuticals, Inc. stock for Q2 2013.
  • 35 funds opened new Anthera Pharmaceuticals, Inc. positions in Q2 2013 and 0 closed out, a net change of +35 holders.

Based on aggregated 13F filings for Q2 2013.